Hepcidin and Erythroferrone in the Anemia of Low-Risk Myelodysplastic Syndromes

被引：1
|
作者：
Oarbeascoa, Gillen [1 ]
Redondo, Sara [2 ]
Jose Moran-Jimenez, Maria [3 ]
Domingo, Amalia [1 ]
Munoz-Linares, Cristina [2 ]
Isabel Moreno-Carralero, Maria [4 ]
Maria Bellon, Jose [5 ]
del Campo Rincon, Juan Francisco [2 ]
Luis Diez-Martin, Jose [1 ,5 ,6 ]
Font, Patricia [1 ,5 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Hematol Dept, Madrid, Spain
[2] Hosp Univ Henares, Hematol Dept, Madrid, Spain
[3] Hosp 12 Octubre I 12, Inst Invest Sanitaria, Madrid, Spain
[4] Hosp 12 Octubre Imas12, Inst Invest Sanitaria, Madrid, Spain
[5] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain
[6] Univ Complutense Madrid, Dept Med, Madrid, Spain
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-116992
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3085
引用
收藏
页数：3
相关论文
共 50 条
  • [1] HEPCIDIN AND ERYTHROFERRONE (ERFE) ARE NOT CORRELATED IN THE ANEMIA OF LOW-RISK MYELODYSPLASTIC SYNDROMES (MDS)
    Redondo, S.
    Oarbeascoa, G.
    Moran Jimenez, M. J.
    Domingo, A.
    Munoz Linares, C.
    Moreno Carralero, M. I.
    Bellon, J. M.
    Del Campo Rincon, J. F.
    Diez-Martin, J. L.
    Font, P.
    HAEMATOLOGICA, 2018, 103 : 183 - 184
  • [2] Erythropoietin for the anemia of low-risk myelodysplastic syndromes
    Fenaux, P
    Ades, L
    BLOOD, 2005, 106 (03) : 768 - 769
  • [3] Treatment of low-risk myelodysplastic syndromes
    Santini, Valeria
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 462 - 469
  • [4] Low-risk myelodysplastic syndromes and iron overload
    Fenaux, Pierre
    HEMATOLOGIE, 2006, 12 : 9 - 9
  • [5] Amifostine in the treatment of low-risk myelodysplastic syndromes
    Grossi, A
    Fabbri, A
    Santini, V
    Leoni, F
    Nozzoli, C
    Longo, G
    Pagliai, G
    Ciolli, S
    Ferrini, PR
    HAEMATOLOGICA, 2000, 85 (04) : 367 - 371
  • [6] rHuEpo treatment in low-risk myelodysplastic syndromes
    Grossi, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (02) : 574 - 574
  • [7] Supportive therapy for low-risk myelodysplastic syndromes
    Gay, Julie
    HEMATOLOGIE, 2008, 14 (03): : 178 - 184
  • [8] DNA instability in low-risk myelodysplastic syndromes: refractory anemia with or without ring sideroblasts
    Novotna, Bozena
    Neuwirtova, Radana
    Siskova, Magda
    Bagryantseva, Yana
    HUMAN MOLECULAR GENETICS, 2008, 17 (14) : 2144 - 2149
  • [9] DNA instability in low-risk myelodysplastic syndromes - refractory anemia with or without ring sideroblasts
    Novotna, B.
    Blazkova, V.
    Neuwirtova, R.
    Siskova, M.
    Bagryantseva, Y.
    LEUKEMIA RESEARCH, 2007, 31 : S72 - S72
  • [10] Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of response
    Viniou, N
    Terpos, E
    Galanopoulos, A
    Kritikou-Griva, E
    Akel, S
    Michalis, E
    Apostolidou, E
    Georgiadou, D
    Kouraklis, A
    Parharidou, A
    Kokkini, G
    Symeonidis, A
    Anagnostopoulos, NI
    Christakis, JI
    Tasiopoulou, A
    Loukopoulos, D
    Yataganas, X
    ANNALS OF HEMATOLOGY, 2002, 81 (04) : 182 - 186
12345